# Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism

> **NCT00800358** · NA · COMPLETED · sponsor: **Penang Hospital, Malaysia** · enrollment: 69 (actual)

## Conditions studied

- Hyperparathyroidism
- Kidney Disease

## Interventions

- **DRUG:** Paricalitol
- **DRUG:** Calcitriol

## Key facts

- **NCT ID:** NCT00800358
- **Lead sponsor:** Penang Hospital, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-10
- **Final completion:** 2009-12
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2012-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800358, "Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00800358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*